DSM signs licence to allow SpineVision to use Bionate II PCU


DSM has announced that it has signed a licence and supply agreement that allows SpineVision to use DSM’s Bionate II PCU polymer in its Flex+2 lumbar stabilisation system.

According to a DSM press release, the Flex+2 system uses a top-loading, top-tightening design, which accommodates both open and percutaneous approaches. The press release reported that DSM’s Bionate II PCU encapsulates the metal wire and provides the system with enhanced frontal and sagittal stabilisation, assuring flexion and extension, which allow for increased freedom of movement and better accommodation to the spine without loss of strength or stability.

William Fuller, director of Business Development at DSM, said: “DSM’s polyurethane materials have a proven clinical history and have been used in several dynamic stabilization devices and implants. Our Bionate II PCU provides increased flexibility and shock absorbing characteristics, replicating the natural movements of the spine. We are proud to see Bionate II PCU contributing to the performance of SpineVision’s Flex+2 system.”

SpineVision will initially launch the Flex+2 system in the European Union. The device is not currently available for sale in the USA.